Last reviewed · How we verify
Upper limb spasticity in pediatric patients
Approved treatments
- Xeomin · Merz Pharms
Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Upper limb spasticity in pediatric patients patent landscape — cliff calendar, originator estates, attackable patents
- Upper limb spasticity in pediatric patients treatment landscape brief
- Upper limb spasticity in pediatric patients treatment updates RSS
Frequently asked questions about Upper limb spasticity in pediatric patients
What drugs treat Upper limb spasticity in pediatric patients?
Tracked treatments include Xeomin.
What is the treatment for Upper limb spasticity in pediatric patients?
Standard treatment for Upper limb spasticity in pediatric patients includes Xeomin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Upper limb spasticity in pediatric patients patent cliff · Upper limb spasticity in pediatric patients CI report
- Treatment: Xeomin · Merz Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing